Financing Dental Support Organization Growth: SBA 7(a) or RBF?

Buying an existing practice, its equipment, goodwill, lease, and patient records, is one of the most common uses of 7(a) loans in healthcare, and lenders who specialize in dental have well-established underwriting models for it. Terms can run up to ten years for equipment and goodwill and up to twenty five for real estate, spreading a large purchase price across years of collections from the acquired patient base.

SBA caps the maximum variable rate a lender can charge at a spread over prime that narrows as the loan grows, from prime plus 6.5 points on the smallest loans to prime plus 3.0 points on loans over $350,000¹, so a meaningful practice acquisition loan typically prices well below what a smaller working-capital note would cost.

Once a DSO has several locations with steady, predictable collections, revenue-based financing can be a reasonable way to fund a smaller need, new equipment at an existing location, a marketing push to fill new patient slots, without going through a full loan application. Collections-based revenue is relatively steady compared with many industries, which makes it a more natural fit for this kind of financing than, say, project-based revenue.

The caveat is insurance reimbursement timing. If a meaningful share of collections comes in weeks after the visit rather than at time of service, make sure the provider is underwriting against actual collected revenue, not billed charges that have not yet cleared.

The dollar amounts involved in a practice acquisition, often covering equipment, goodwill, and sometimes real estate together, are large enough that the interest rate difference between a 7(a) loan and a revenue-based advance compounds into a meaningful sum over the life of the deal. A percentage-of-revenue repayment structure sized to cover a full acquisition price would also claim a large enough share of ongoing collections to strain the practice's operating cash flow in a way a properly amortized term loan does not.

The SBA process takes weeks, so start it as early as a target practice is identified rather than after a letter of intent is already signed and the seller is expecting a fast close.

A DSO pursuing several acquisitions at once should avoid financing them all through one blended facility. Structure each acquisition's SBA loan against that specific location's projected collections and existing patient base, so an underperforming new location does not put the financing for a strong, already-integrated one at risk.

Keep a separate working capital line, sized modestly, for the transition period right after each acquisition closes, when patient retention and staff integration are still settling and cash flow is more volatile than it will be a year in. This location-by-location discipline also makes it far easier to spot, early, which acquisitions are performing to plan and which need operational attention before a small integration problem becomes a financing problem.

Keep each acquisition on its own footing:

• Finance each acquisition with its own SBA loan, sized against that location's projected collections and existing patient base.
• Keep a strong location's financing separate from a newer one still finding its footing, so an underperformer does not drag it down.
• Start the loan process as soon as a target practice is identified, since closing takes several weeks.
• Use a modest working capital line, not a percentage-of-revenue advance, to cover a new location's transition period.

The common error is using revenue-based financing or a merchant cash advance to bridge the gap during an acquisition's due diligence period because it is faster than waiting on an SBA approval, then discovering the advance's repayment schedule collides with the new location's already-thin transition-period cash flow. That stacks two sources of strain, integration costs and advance repayment, at exactly the moment the practice can least absorb it.

Plan the SBA timeline into your acquisition calendar from the start, and use a modest working capital line rather than a revenue-based advance for the transition period itself. MeetMyCXO's AI CFO can help model both against your specific acquisition pipeline.

A related misstep is underestimating how much patient attrition a change in ownership can cause in the first several months, even when the clinical team stays the same. Build that expected dip into your projections before sizing the acquisition loan, rather than assuming collections continue exactly where the seller's numbers left off on day one.